REGN vs UPS · P/E 14, rev $14.34B vs P/E 15, rev $88.66B
Regeneron Pharmaceuticals Inc (REGN) versus United Parcel Service Inc (UPS) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
United Parcel Service Inc (UPS) is a integrated freight & logistics company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported UPS revenue for 2025-12-31 was $88.66B. Net income was $5.57B. Revenue was down 2.6% from 2024-12-31 to 2025-12-31. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
Not investment advice. Open the REGN and UPS stock pages for the full models.
Not investment advice.